company background image
600721 logo

Xinjiang Bai Hua Cun Pharma TechLtd SHSE:600721 Stock Report

Last Price

CN¥5.70

Market Cap

CN¥2.1b

7D

11.1%

1Y

-10.9%

Updated

26 Apr, 2024

Data

Company Financials

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

SHSE:600721 Stock Report

Market Cap: CN¥2.1b

600721 Stock Overview

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in the pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses.

600721 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for 600721 from our risk checks.

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Xinjiang Bai Hua Cun Pharma TechLtd
Historical stock prices
Current Share PriceCN¥5.70
52 Week HighCN¥11.21
52 Week LowCN¥4.31
Beta0.13
1 Month Change-9.95%
3 Month Change-16.54%
1 Year Change-10.94%
3 Year Change45.41%
5 Year Change0.18%
Change since IPO-9.65%

Recent News & Updates

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd's (SHSE:600721) P/S Is Still On The Mark Following 34% Share Price Bounce

Mar 08
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd's (SHSE:600721) P/S Is Still On The Mark Following 34% Share Price Bounce

Recent updates

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd's (SHSE:600721) P/S Is Still On The Mark Following 34% Share Price Bounce

Mar 08
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd's (SHSE:600721) P/S Is Still On The Mark Following 34% Share Price Bounce

Shareholder Returns

600721CN PharmaceuticalsCN Market
7D11.1%3.3%-0.3%
1Y-10.9%-14.4%-14.6%

Return vs Industry: 600721 exceeded the CN Pharmaceuticals industry which returned -14.4% over the past year.

Return vs Market: 600721 exceeded the CN Market which returned -14.6% over the past year.

Price Volatility

Is 600721's price volatile compared to industry and market?
600721 volatility
600721 Average Weekly Movement9.2%
Pharmaceuticals Industry Average Movement7.6%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.2%

Stable Share Price: 600721 has not had significant price volatility in the past 3 months.

Volatility Over Time: 600721's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1959731Hui Huangwww.xjbhc.net

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in the pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. The company was formerly known as Xinjiang Baihuacun Co., Ltd. and changed its name to Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd in July 2021.

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Fundamentals Summary

How do Xinjiang Bai Hua Cun Pharma TechLtd's earnings and revenue compare to its market cap?
600721 fundamental statistics
Market capCN¥2.10b
Earnings (TTM)-CN¥28.06m
Revenue (TTM)CN¥359.24m

6.1x

P/S Ratio

-77.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600721 income statement (TTM)
RevenueCN¥359.24m
Cost of RevenueCN¥243.13m
Gross ProfitCN¥116.11m
Other ExpensesCN¥144.17m
Earnings-CN¥28.06m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.073
Gross Margin32.32%
Net Profit Margin-7.81%
Debt/Equity Ratio0%

How did 600721 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.